Combination of Sorafenib and Vorinostat in Poor-risk Acute Myelogenous Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)

Clinical trial NCT00875745 · COMPLETED

Trial details

NCT number: NCT00875745
Sponsor: Indiana University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia, Myeloid, Acute Leukemia, Promyelocytic, Acute Myelodysplastic Syndromes

Start date: 2009-04-01
Primary completion: 2010-05-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.